Clinical trial
A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma
NCT00140855 · Ludwig Institute for Cancer Research, Other · Terminated
Key facts
| NCT number | NCT00140855 |
|---|---|
| Title | A Study of Anti-CTLA-4 Antibody in Patients With Advanced Synovial Sarcoma |
| Official title | A Phase II Study of Anti-CTLA-4 Antibody in Advanced Synovial Sarcoma Patients |
| Lead sponsor | Ludwig Institute for Cancer Research, Other |
| Collaborators | Medarex Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Synovial Sarcoma |
| Intervention type | Biological |
| Interventions | ipilimumab |
| Enrollment | 6 |
| Start date | Jun 8, 2005 |
| Primary completion | Apr 18, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 1, 2005 |
| Last update posted | Oct 12, 2022 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: